Rationale and prospects of targeting bacterial two-component systems for antibacterial treatment of cystic fibrosis patients

Nadya Velikova*, Jerry M. Wells

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

Bacterial respiratory infections are the main reason of morbidity and mortality among cystic fibrosis (CF) patients. In early childhood, the respiratory infections are due to Staphylococcus aureus and Haemophilus influenzae. In older CF patients, pathogenic Gram-negative bacteria like Achromobacter xylosoxidans, Burkholderia cepacia complex and especially Pseudomonas aeruginosa are more frequently seen. P. aeruginosa is a turning point in the respiratory disease in CF and its predominance increases with age. Bacteria use a variety of two-component systems (TCS) to differentially express virulence factors involved in both acute and chronic infections. Here, we review bacterial TCS as targets for antibacterial treatment for CF patients.
Original languageEnglish
JournalCurrent Drug Targets
Volume17
Issue number16
DOIs
Publication statusPublished - 2016

Keywords

  • Bacterial infections
  • Cystic fibrosis
  • Two-component systems

Fingerprint Dive into the research topics of 'Rationale and prospects of targeting bacterial two-component systems for antibacterial treatment of cystic fibrosis patients'. Together they form a unique fingerprint.

  • Cite this